Skip to main content
Top
Published in: Respiratory Research 1/2014

Open Access 01-12-2014 | Research

Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease

Authors: Kohei Hasegawa, Yusuke Tsugawa, Chu-Lin Tsai, David FM Brown, Carlos A Camargo Jr

Published in: Respiratory Research | Issue 1/2014

Login to get access

Abstract

Background

Little is known about patients who frequently visit the emergency department (ED) for acute exacerbation of chronic obstructive pulmonary disease (AECOPD). We aimed to quantify the proportion and characteristics of patients with frequent ED visits for AECOPD and associated healthcare utilization.

Methods

We conducted a retrospective cohort study of adults aged ≥40 years with at least one ED visit for AECOPD between 2010 and 2011, derived from population-based all-payer data of State ED and Inpatient Databases for two large and diverse states: California and Florida. Outcome measures were frequency of ED visits for AECOPD, 30-day ED revisits, subsequent hospitalizations, near-fatal events (AECOPD involving mechanical ventilation), and charges for both ED and inpatient services (available only for Florida) during the year after the first ED visit.

Results

The analytic cohort comprised 98,280 unique patients with 154,736 ED visits for AECOPD. During the 1-year period, 29.4% (95% CI, 29.1%-29.7%) of the patients had two or more (frequent) visits, accounting for 55.2% (95% CI, 54.9%-55.4%) of all ED visits for AECOPD. In the multivariable model, significant predictors of frequent ED visits were age 55–74 years (vs. 40–54 years), male sex, non-Hispanic white or black race, Medicaid insurance (vs. private), and lower median household income (all P < 0.001). At the visit-level, 12.3% of ED visits for AECOPD were 30-day revisit events (95% CI, 12.1%-12.4%). Additionally, 62.8% of ED visits for AECOPD (95% CI, 62.6%-63.0%) resulted in a hospitalization; patients with frequent ED visits comprised 55.5% (95% CI, 55.2%-55.8%) of all hospitalizations. Furthermore, 7.3% (95% CI, 7.3%-7.5%) of ED visits for AECOPD led to a near-fatal event; patients with frequent ED visits accounted for 64.4% (95% CI, 63.5%-65.3%) of all near-fatal events. Total charges for AECOPD were $1.94 billion (95% CI, $1.90-1.97 billion) in Florida; patients with frequent ED visits accounted for $1.07 billion (95% CI, $1.04-1.09 billion).

Conclusions

In this large cohort study, we found that 29% had frequent ED visits for AECOPD and that lower socioeconomic status was significantly associated with a higher frequency of ED visits. Individuals with frequent ED visits for AECOPD accounted for a substantial amount of healthcare utilization and financial burden.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH: Chronic obstructive pulmonary disease surveillance-United States, 1999–2011. Chest. 2013, 144: 284-305. 10.1378/chest.13-0809.PubMedPubMedCentralCrossRef Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH: Chronic obstructive pulmonary disease surveillance-United States, 1999–2011. Chest. 2013, 144: 284-305. 10.1378/chest.13-0809.PubMedPubMedCentralCrossRef
2.
go back to reference Kanner RE, Anthonisen NR, Connett JE, Group LHSR: Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med. 2001, 164: 358-364. 10.1164/ajrccm.164.3.2010017.PubMedCrossRef Kanner RE, Anthonisen NR, Connett JE, Group LHSR: Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med. 2001, 164: 358-364. 10.1164/ajrccm.164.3.2010017.PubMedCrossRef
3.
go back to reference Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA: Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002, 57: 847-852. 10.1136/thorax.57.10.847.PubMedPubMedCentralCrossRef Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA: Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002, 57: 847-852. 10.1136/thorax.57.10.847.PubMedPubMedCentralCrossRef
4.
go back to reference Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA: Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998, 157: 1418-1422. 10.1164/ajrccm.157.5.9709032.PubMedCrossRef Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA: Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998, 157: 1418-1422. 10.1164/ajrccm.157.5.9709032.PubMedCrossRef
6.
go back to reference Strassels SA, Smith DH, Sullivan SD, Mahajan PS: The costs of treating COPD in the United States. Chest. 2001, 119: 344-352. 10.1378/chest.119.2.344.PubMedCrossRef Strassels SA, Smith DH, Sullivan SD, Mahajan PS: The costs of treating COPD in the United States. Chest. 2001, 119: 344-352. 10.1378/chest.119.2.344.PubMedCrossRef
8.
go back to reference Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA: Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010, 363: 1128-1138. 10.1056/NEJMoa0909883.PubMedCrossRef Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA: Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010, 363: 1128-1138. 10.1056/NEJMoa0909883.PubMedCrossRef
9.
go back to reference Kim V, Han MK, Vance GB, Make BJ, Newell JD, Hokanson JE, Hersh CP, Stinson D, Silverman EK, Criner GJ, Investigators CO: The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest. 2011, 140: 626-633. 10.1378/chest.10-2948.PubMedPubMedCentralCrossRef Kim V, Han MK, Vance GB, Make BJ, Newell JD, Hokanson JE, Hersh CP, Stinson D, Silverman EK, Criner GJ, Investigators CO: The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest. 2011, 140: 626-633. 10.1378/chest.10-2948.PubMedPubMedCentralCrossRef
10.
go back to reference Yeatts KB, Lippmann SJ, Waller AE, Lich KH, Travers D, Weinberger M, Donohue JF: Population-based Burden of COPD-related Visits in the Emergency Department (ED): Return ED Visits, Hospital Admissions, and Comorbidity Risks. Chest. 2013, 144: 784-793. 10.1378/chest.12-1899.PubMedCrossRef Yeatts KB, Lippmann SJ, Waller AE, Lich KH, Travers D, Weinberger M, Donohue JF: Population-based Burden of COPD-related Visits in the Emergency Department (ED): Return ED Visits, Hospital Admissions, and Comorbidity Risks. Chest. 2013, 144: 784-793. 10.1378/chest.12-1899.PubMedCrossRef
11.
go back to reference Tsai CL, Griswold SK, Clark S, Camargo CA: Factors associated with frequency of emergency department visits for chronic obstructive pulmonary disease exacerbation. J Gen Intern Med. 2007, 22: 799-804. 10.1007/s11606-007-0191-7.PubMedPubMedCentralCrossRef Tsai CL, Griswold SK, Clark S, Camargo CA: Factors associated with frequency of emergency department visits for chronic obstructive pulmonary disease exacerbation. J Gen Intern Med. 2007, 22: 799-804. 10.1007/s11606-007-0191-7.PubMedPubMedCentralCrossRef
16.
go back to reference Elixhauser A, Steiner C, Harris DR, Coffey RM: Comorbidity measures for use with administrative data. Med Care. 1998, 36: 8-27. 10.1097/00005650-199801000-00004.PubMedCrossRef Elixhauser A, Steiner C, Harris DR, Coffey RM: Comorbidity measures for use with administrative data. Med Care. 1998, 36: 8-27. 10.1097/00005650-199801000-00004.PubMedCrossRef
17.
go back to reference Hasegawa K, Brown DF, Tsugawa Y, Camargo CA: Epidemiology of emergency department visits for opioid overdose: a population-based study. Mayo Clin Proc. 2014, 89 (4): 462-471. 10.1016/j.mayocp.2013.12.008.PubMedCrossRef Hasegawa K, Brown DF, Tsugawa Y, Camargo CA: Epidemiology of emergency department visits for opioid overdose: a population-based study. Mayo Clin Proc. 2014, 89 (4): 462-471. 10.1016/j.mayocp.2013.12.008.PubMedCrossRef
19.
go back to reference McCullagh P, Nelder JA: Generalized Linear Models (Monographs on statistics and applied probability 37). 1989, London: Chapman Hall McCullagh P, Nelder JA: Generalized Linear Models (Monographs on statistics and applied probability 37). 1989, London: Chapman Hall
21.
go back to reference Tsai CL: Appropriate statistical treatment of frequent emergency department visits in health services research. Ann Emerg Med. 2007, 49: 385-PubMedCrossRef Tsai CL: Appropriate statistical treatment of frequent emergency department visits in health services research. Ann Emerg Med. 2007, 49: 385-PubMedCrossRef
23.
go back to reference Sharma G, Kuo YF, Freeman JL, Zhang DD, Goodwin JS: Outpatient follow-up visit and 30-day emergency department visit and readmission in patients hospitalized for chronic obstructive pulmonary disease. Arch Intern Med. 2010, 170: 1664-1670.PubMedPubMedCentral Sharma G, Kuo YF, Freeman JL, Zhang DD, Goodwin JS: Outpatient follow-up visit and 30-day emergency department visit and readmission in patients hospitalized for chronic obstructive pulmonary disease. Arch Intern Med. 2010, 170: 1664-1670.PubMedPubMedCentral
24.
go back to reference Kim S, Emerman CL, Cydulka RK, Rowe BH, Clark S, Camargo CA, Investigators M: Prospective multicenter study of relapse following emergency department treatment of COPD exacerbation. Chest. 2004, 125: 473-481. 10.1378/chest.125.2.473.PubMedCrossRef Kim S, Emerman CL, Cydulka RK, Rowe BH, Clark S, Camargo CA, Investigators M: Prospective multicenter study of relapse following emergency department treatment of COPD exacerbation. Chest. 2004, 125: 473-481. 10.1378/chest.125.2.473.PubMedCrossRef
25.
go back to reference Baillargeon J, Wang Y, Kuo YF, Holmes HM, Sharma G: Temporal trends in hospitalization rates for older adults with chronic obstructive pulmonary disease. Am J Med. 2013, 126: 607-614. 10.1016/j.amjmed.2013.01.035.PubMedCrossRef Baillargeon J, Wang Y, Kuo YF, Holmes HM, Sharma G: Temporal trends in hospitalization rates for older adults with chronic obstructive pulmonary disease. Am J Med. 2013, 126: 607-614. 10.1016/j.amjmed.2013.01.035.PubMedCrossRef
26.
go back to reference Rabe KF, Wedzicha JA: Controversies in treatment of chronic obstructive pulmonary disease. Lancet. 2011, 378: 1038-1047. 10.1016/S0140-6736(11)61295-6.PubMedCrossRef Rabe KF, Wedzicha JA: Controversies in treatment of chronic obstructive pulmonary disease. Lancet. 2011, 378: 1038-1047. 10.1016/S0140-6736(11)61295-6.PubMedCrossRef
27.
go back to reference Chiu S, Kelton C, Guo J, Wigle P, Lin A, Szeinbach S: Utilization, spending, and price trends for long-acting beta agonists and inhaled corticosteroids in the US Medicaid program from 1991 to 2010. Am Health Drug Benefits. 2011, 4: 140-149.PubMedPubMedCentral Chiu S, Kelton C, Guo J, Wigle P, Lin A, Szeinbach S: Utilization, spending, and price trends for long-acting beta agonists and inhaled corticosteroids in the US Medicaid program from 1991 to 2010. Am Health Drug Benefits. 2011, 4: 140-149.PubMedPubMedCentral
28.
go back to reference Setse RW, Euler GL, Gonzalez-Feliciano AG, Bryan LN, Furlow C, Weinbaum CM, Singleton JA: Influenza Vaccination Coverage—United States, 2000–2010. MMWR Surveill Summ. 2011, 60: 38-41.PubMed Setse RW, Euler GL, Gonzalez-Feliciano AG, Bryan LN, Furlow C, Weinbaum CM, Singleton JA: Influenza Vaccination Coverage—United States, 2000–2010. MMWR Surveill Summ. 2011, 60: 38-41.PubMed
29.
go back to reference Centers for Disease Control and Prevention: Trends in Current Cigarette Smoking Among high Hschool Students and Adults, United States, 1965--2010. 2011, Atlanta, GA: US Department of Health and Human Services; 2011 Centers for Disease Control and Prevention: Trends in Current Cigarette Smoking Among high Hschool Students and Adults, United States, 1965--2010. 2011, Atlanta, GA: US Department of Health and Human Services; 2011
30.
go back to reference Chavez PC, Shokar NK: Diagnosis and management of chronic obstructive pulmonary disease (COPD) in a primary care clinic. COPD. 2009, 6: 446-451. 10.3109/15412550903341455.PubMedCrossRef Chavez PC, Shokar NK: Diagnosis and management of chronic obstructive pulmonary disease (COPD) in a primary care clinic. COPD. 2009, 6: 446-451. 10.3109/15412550903341455.PubMedCrossRef
32.
go back to reference Canino G, McQuaid EL, Rand CS: Addressing asthma health disparities: a multilevel challenge. J Allergy Clin Immunol. 2009, 123: 1209-1217. 10.1016/j.jaci.2009.02.043. quiz 1218–1209PubMedPubMedCentralCrossRef Canino G, McQuaid EL, Rand CS: Addressing asthma health disparities: a multilevel challenge. J Allergy Clin Immunol. 2009, 123: 1209-1217. 10.1016/j.jaci.2009.02.043. quiz 1218–1209PubMedPubMedCentralCrossRef
33.
go back to reference Lange P, Marott JL, Vestbo J, Ingebrigtsen TS, Nordestgaard BG: Socioeconomic Status and Prognosis of COPD in Denmark. COPD. 2014, [Epub ahead of print] Lange P, Marott JL, Vestbo J, Ingebrigtsen TS, Nordestgaard BG: Socioeconomic Status and Prognosis of COPD in Denmark. COPD. 2014, [Epub ahead of print]
35.
go back to reference Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, Make BJ, Rabe KF, Rennard SI, Sciurba FC, Silverman EK, Vestbo J, Washko GR, Wouters EF, Martinez FJ: Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010, 182: 598-604. 10.1164/rccm.200912-1843CC.PubMedCrossRef Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, Make BJ, Rabe KF, Rennard SI, Sciurba FC, Silverman EK, Vestbo J, Washko GR, Wouters EF, Martinez FJ: Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010, 182: 598-604. 10.1164/rccm.200912-1843CC.PubMedCrossRef
37.
go back to reference Basu J, Mobley LR: Do HMOs reduce preventable hospitalizations for Medicare beneficiaries?. Med Care Res Rev. 2007, 64: 544-567. 10.1177/1077558707301955.PubMedCrossRef Basu J, Mobley LR: Do HMOs reduce preventable hospitalizations for Medicare beneficiaries?. Med Care Res Rev. 2007, 64: 544-567. 10.1177/1077558707301955.PubMedCrossRef
38.
go back to reference Hasegawa K, Tsugawa Y, Brown DF, Mansbach JM, Camargo CA: Temporal trends in emergency department visits for bronchiolitis in the United States, 2006–2010. Pediatr Infect Dis J. 2014, 33: 11-18. 10.1097/INF.0b013e3182a5f324.PubMedPubMedCentralCrossRef Hasegawa K, Tsugawa Y, Brown DF, Mansbach JM, Camargo CA: Temporal trends in emergency department visits for bronchiolitis in the United States, 2006–2010. Pediatr Infect Dis J. 2014, 33: 11-18. 10.1097/INF.0b013e3182a5f324.PubMedPubMedCentralCrossRef
39.
go back to reference Effing T, Monninkhof EM, van der Valk PD, van der Palen J, van Herwaarden CL, Partidge MR, Walters EH, Zielhuis GA: Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007, CD002990-4 Effing T, Monninkhof EM, van der Valk PD, van der Palen J, van Herwaarden CL, Partidge MR, Walters EH, Zielhuis GA: Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007, CD002990-4
40.
go back to reference O’Malley AS, Pham HH, Schrag D, Wu B, Bach PB: Potentially avoidable hospitalizations for COPD and pneumonia: the role of physician and practice characteristics. Med Care. 2007, 45: 562-570. 10.1097/MLR.0b013e3180408df8.PubMedCrossRef O’Malley AS, Pham HH, Schrag D, Wu B, Bach PB: Potentially avoidable hospitalizations for COPD and pneumonia: the role of physician and practice characteristics. Med Care. 2007, 45: 562-570. 10.1097/MLR.0b013e3180408df8.PubMedCrossRef
Metadata
Title
Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease
Authors
Kohei Hasegawa
Yusuke Tsugawa
Chu-Lin Tsai
David FM Brown
Carlos A Camargo Jr
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2014
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-15-40

Other articles of this Issue 1/2014

Respiratory Research 1/2014 Go to the issue